Imugene Ltd (IMU) - Total Liabilities

Latest as of December 2025: AU$25.80 Million AUD ≈ $18.26 Million USD

Based on the latest financial reports, Imugene Ltd (IMU) has total liabilities worth AU$25.80 Million AUD (≈ $18.26 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Imugene Ltd - Total Liabilities Trend (1993–2025)

This chart illustrates how Imugene Ltd's total liabilities have evolved over time, based on quarterly financial data. See Imugene Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Imugene Ltd Competitors by Total Liabilities

The table below lists competitors of Imugene Ltd ranked by their total liabilities.

Company Country Total Liabilities
Drone Volt SA
PA:ALDRV
France €8.88 Million
Gunpoint Exploration Ltd
V:GUN
Canada CA$335.00K
Kunming Longjin Pharmaceutical Co Ltd
SHE:002750
China CN¥69.96 Million
Hudson Global Inc
NASDAQ:HSON
USA $15.45 Million
Shengfeng Development Limited Class A Ordinary Shares
NASDAQ:SFWL
USA $166.27 Million
PTL LTD Ordinary Shares
NASDAQ:PTLE
USA $425.73K
FiEE, Inc.
NASDAQ:FIEE
USA $2.94 Million
Nexam Chemical Holding AB
ST:NEXAM
Sweden Skr57.20 Million

Liability Composition Analysis (1993–2025)

This chart breaks down Imugene Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IMU stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.78 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.77 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.62 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Imugene Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Imugene Ltd (1993–2025)

The table below shows the annual total liabilities of Imugene Ltd from 1993 to 2025.

Year Total Liabilities Change
2025-06-30 AU$38.56 Million
≈ $27.28 Million
+16.33%
2024-06-30 AU$33.14 Million
≈ $23.45 Million
+345.66%
2023-06-30 AU$7.44 Million
≈ $5.26 Million
-16.45%
2022-06-30 AU$8.90 Million
≈ $6.30 Million
+31.06%
2021-06-30 AU$6.79 Million
≈ $4.81 Million
+25.80%
2020-06-30 AU$5.40 Million
≈ $3.82 Million
+54.93%
2019-06-30 AU$3.48 Million
≈ $2.47 Million
+142.19%
2018-06-30 AU$1.44 Million
≈ $1.02 Million
+12.15%
2017-06-30 AU$1.28 Million
≈ $907.76K
-23.60%
2016-06-30 AU$1.68 Million
≈ $1.19 Million
+21.45%
2015-06-30 AU$1.38 Million
≈ $978.36K
-27.20%
2014-06-30 AU$1.90 Million
≈ $1.34 Million
+172.09%
2013-06-30 AU$698.03K
≈ $493.90K
+184.94%
2012-06-30 AU$244.97K
≈ $173.33K
-48.99%
2011-06-30 AU$480.28K
≈ $339.83K
+56.25%
2010-06-30 AU$307.37K
≈ $217.49K
-29.62%
2009-06-30 AU$436.72K
≈ $309.01K
-11.48%
2008-06-30 AU$493.37K
≈ $349.09K
-11.99%
2007-06-30 AU$560.55K
≈ $396.62K
-30.46%
2006-06-30 AU$806.04K
≈ $570.32K
+95.87%
2005-06-30 AU$411.52K
≈ $291.18K
-29.57%
2004-06-30 AU$584.29K
≈ $413.43K
-16.62%
2003-06-30 AU$700.77K
≈ $495.84K
+1259.15%
2002-06-30 AU$51.56K
≈ $36.48K
-98.07%
2001-06-30 AU$2.67 Million
≈ $1.89 Million
+195.33%
2000-06-30 AU$903.09K
≈ $638.99K
+0.57%
1999-06-30 AU$898.00K
≈ $635.39K
-20.95%
1998-06-30 AU$1.14 Million
≈ $803.79K
-8.46%
1997-06-30 AU$1.24 Million
≈ $878.09K
+10.12%
1996-06-30 AU$1.13 Million
≈ $797.42K
-13.64%
1995-06-30 AU$1.30 Million
≈ $923.37K
+927.56%
1994-06-30 AU$127.00K
≈ $89.86K
-78.36%
1993-06-30 AU$587.00K
≈ $415.34K
--

About Imugene Ltd

AU:IMU Australia Biotechnology
Market Cap
$34.56 Million
AU$48.84 Million AUD
Market Cap Rank
#23297 Global
#881 in Australia
Share Price
AU$0.12
Change (1 day)
+21.05%
52-Week Range
AU$0.01 - AU$0.48
All Time High
AU$0.61
About

Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA,… Read more